Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2006 February;97(1) > Minerva Medica 2006 February;97(1):25-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

REVIEWS  HELICOBACTER PYLORI: THE BACTERIUM OF 2005 NOBEL PRIZE


Minerva Medica 2006 February;97(1):25-9

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: Italian

Invasive diagnosis of Helicobacter pylori infection in the 2006 clinical practice

Repici A., Pellicano R., Astegiano M., Saracco G., De Angelis C., Debernardi W., Berrutti M., Rizzetto M.

1 Servizio Endoscopia Digestiva Istituto Clinico Humanitas, Rozzano, Milano 2 S.C.D.U. Gastro-Epatologia Azienda Ospedaliera San Giovanni Battista (Molinette), Torino 3 Dipartimento di Medicina Interna Università degli Studi di Torino, Torin


PDF  


Currently, different approaches are employed to detect the presence of Helicobacter pylori (H. pylori): invasive, if based on biopsies performed during endoscopy (urease test, histology, culture, polymerase chain reaction), and non-invasive, if endoscopy is not carried out. Another option is offered by the invasive non-endoscopic methods (string test). An update on the diagnostic invasive approaches to patients in the clinical setting is presented in this review. Although non-invasive tests are preferred, important information can be gained from histology, the unique technique which permits the evaluation of the status of the mucosa, and from culture, that allows strain typing and tests for antibiotic susceptibility. Until today, polymerase chain reaction has had a limited application in the clinical practice and the role of non-endoscopic methods needs to be better clarified in the future.

top of page

Publication History

Cite this article as

Corresponding author e-mail